Physician

Ehteshamul Haque Anjum, M.D.

According to 2025 Medicare claims, Ehteshamul Anjum, M.D. (NPI: 1932229390) practices nephrology in the Janesville-Beloit, WI market, with the plurality of this provider's patient population coming from Rock, WI. This provider's primary affiliated billing organization is MERCY HEALTH SYSTEM CORPORATION (NPI: 1598718603; TIN: 390816848) and primary practice location at 53548-2940. Anjum is affiliated with the Mercy Health Corporation (ACO ID: A2097) and Gundersen ACO (ACO ID: A5094), participating under the MSSP model.

Anjum's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 423 traditional Medicare patients, billed 1,709 HCPCS/CPT codes, and received $158,944 in Medicare payments. The top billing code was 90961 (Dialysis services, 2-3 physician visits per month (20 years or older)). Part D data shows 1,814 prescription claims across 323 beneficiaries totaling $348,651 in drug costs, led by Jynarque (Tolvaptan). 2022 DME data shows 53 claims. Open Payments data shows 1 records totaling $15. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $147,821 to $348,651. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	371	1,764	$138,541
2016	434	1,968	$154,540
2017	488	2,217	$175,454
2018	494	2,621	$184,615
2019	487	2,445	$179,510
2020	446	2,362	$153,312
2021	432	2,386	$202,307
2022	418	1,725	$170,224
2023	403	1,790	$160,360
2024	423	1,709	$158,944

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	171	1,003	$147,821
2016	218	1,356	$195,243
2017	247	1,625	$280,002
2018	262	1,604	$160,201
2019	293	1,773	$172,603
2020	279	1,857	$112,450
2021	281	1,708	$306,853
2022	292	1,736	$429,095
2023	288	1,605	$352,442
2024	323	1,814	$348,651

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	31	$1,088
2022	N/R	53	$15,777
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90961	Dialysis services, 2-3 physician visits per month (20 years or older)	30	145	$223
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	97	129	$96
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	58	58	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	269	501	$68
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	96	487	$60

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jynarque	Tolvaptan	13	364	$251,027
Lokelma	Sodium Zirconium Cyclosilicate	39	2,218	$26,649
Potassium Citrate Er	Potassium Citrate	77	5,940	$11,812
Sevelamer Carbonate	Sevelamer Carbonate	48	2,144	$9,023
Lanthanum Carbonate	Lanthanum Carbonate	13	345	$7,569

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$15	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ehteshamul Haque Anjum, M.D.?

Tedicare shows public-source Medicare data for Ehteshamul Haque Anjum, M.D. (NPI 1932229390), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ehteshamul Haque Anjum, M.D. have ACO affiliation data?

Ehteshamul Haque Anjum, M.D. is shown with ACO affiliation data for Mercy Health Corporation (MSSP, ACO ID A2097) and Gundersen ACO (MSSP, ACO ID A5094).

What billing organization is linked to Ehteshamul Haque Anjum, M.D.?

Ehteshamul Haque Anjum, M.D. is linked to MERCY HEALTH SYSTEM CORPORATION (billing NPI 1598718603) in the available physician profile data.

Does Ehteshamul Haque Anjum, M.D. have Open Payments data?

Ehteshamul Haque Anjum, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.